Why the study?
Identification and functional assessment of new NaV1.7 mutations could help elucidate the phenotypic spectrum of NaV1.7 channelopathies.
Answers are grounded in this paper and cite their sources.
The identification of the E44Q gain-of-function mutation in NaV1.7 expands the phenotypic spectrum of NaV1.7 channelopathies to include infantile paroxysmal knee pain.
Gain-of-function mutations in voltage-gated sodium channels (Na V 1.7, Na V 1.8, and Na V 1.9) are known causes of inherited pain disorders. Identification and functional assessment of new Na V 1.7 mutations could help elucidate the phenotypic spectrum of Na V 1.7 channelopathies. We identified a novel Na V 1.7 mutation (E44Q in exon 2) that substitutes a glutamic acid residue for glutamine in the cytoplasmic N-terminus of Na V 1.7 in a patient with paroxysmal pain attacks during childhood and his family who experienced similar pain episodes. To study the sodium channel's function, we performed electrophysiological recordings. Voltage-clamp recordings revealed that the mutation increased the amplitude of the non-inactivating component of the sodium current, which might facilitate channel opening. These data demonstrate that E44Q is a gain-of-function mutation in Na V 1.7, which is consistent with our patient's pain phenotype.
No takes yet. Share an insight, caveat, or question.
Takahashi et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: